65,437 trials
Schizophrenia
Primary: Change From Baseline in Positive and Negative Syndrome Scale (PANSS) Total Scores at Week 5 of the Double-Blind Period — -16.9; -7.7 Score on a Scale — p=0.0014
Overactive Bladder
Primary: UUI Responder — 72 Participants
Obesity
Primary: Body Mass (Weight) — -2.1067; -2.1887 kg
Copd
Primary: Number of PRN Respiratory Therapy Drugs Per Day (PRN Treatments With Short Acting Bronchodilators Via Nebulization Given by Respiratory Therapists). — 0.03 treatments…
Alcohol Use Disorder
Primary: Recruitment Rate — 19 Participants
Pruritus
Primary: Change in Peak Pruritus Numerical Rating Score (PRNS) — -3.1 score on a scale
T-cell Lymphoma · Angioimmunoblastic T-cell Lymphoma · Hepato-splenic T-cell Lymphoma
Primary: Overall Response Rate — 89.5 percentage of participants
Asthma
Primary: Main Study: Number of Participants With Any Treatment-Emergent Adverse Events (TEAEs) — 85; 147 Participants
Type 2 Diabetes Mellitus · Cardiovascular Diseases
Primary: Incidence of 3-point Major Adverse Cardiovascular Events (MACE) — 11,348; 393; 424; 296 Participants
Hypofibrinogenemia · Bleeding
Primary: Total Number of RBCs Used Over Admission — 5.8; 6.7 RBC Units
Parkinson's Disease
Primary: Association Between Basal Ganglia Beta Power and Effort Level (Beta Coefficient) — -0.175 beta coefficient — p=0.007
COPD Exacerbation
Primary: Adherence to Pulmonary Rehabilitation (PR) — 82; 95 Participants
Non-Alcoholic Fatty Liver Disease · Obesity · Obesity, Abdominal
Primary: Liver Fat Content — -5.3; 3.6 percent change in hepatic fat fraction
Opioid Use · Chronic Pain
Primary: Yoga Dosage — 164.5; 99.4; 139.1; 102.2 Total yoga Minutes — p=0.028
Thumb Carpometacarpal Osteoarthritis · Thumb Basal Joint Osteoarthritis
Primary: Subluxation of Thumb Carpometacarpal Joint as Per CAT Scan — .66 millimeters